Researchers at the University of Exeter’s MRC Centre for Medical Mycology have discovered that the fungus Candida albicans and the bacterium Staphylococcus aureus form a cooperative “copper economy” to survive and grow within mixed biofilms. According to a study published in the journal Microbiology, these pathogens manage copper levels to support one another.
How do bacteria and fungi cooperate in biofilms?
Microbes often form biofilms—surface-attached communities—to protect themselves from environmental threats and medical treatments. Dr. Seána Duggan and her team found that in mixed infections, C. albicans and S. aureus divide the labor of copper management. Protein analysis reveals that the fungus increases its copper uptake, while the bacterium focuses on copper export and stress protection. This division of labor allows the two species to thrive in environments that would typically be toxic to them individually, according to the Exeter researchers.
Mixed fungal-bacterial biofilms are found in wounds, bloodstream infections, and infections linked to medical devices, making them a significant clinical challenge.
Why is the “copper economy” a target for new treatments?
The partnership between these pathogens relies on a delicate balance of copper. Dr. Duggan’s team demonstrated that when this balance is disturbed—either through excess copper or by limiting its availability—the microbial community weakens and the cooperation collapses. This sensitivity suggests that future clinical strategies could involve targeted interventions that disrupt this shared “currency,” potentially breaking down stubborn biofilms.
What are the future implications for clinical practice?
The Exeter study suggests that clinicians may need to consider the cooperative behaviours that can emerge when fungi and bacteria grow together. By identifying the molecular mechanisms that cause these partnerships to fail, researchers aim to develop more effective ways to clear infections that involve multiple, co-existing microbes. The research highlights that micronutrients like copper act as key regulators in determining whether pathogens compete or cooperate.
Comparison: Single vs. Mixed Biofilm Sensitivity
| Condition | Sensitivity to Copper Disruption |
|---|---|
| Single Pathogen | Lower |
| Mixed Biofilm | Higher |
Frequently Asked Questions
Why are mixed biofilms harder to treat than single-species infections?
Mixed biofilms are challenging because different organisms can protect or support one another, making infections harder to clear.
What role does copper play in these infections?
Copper acts as a “shared currency” that helps the fungus and bacterium cooperate. While high levels of copper are typically toxic to microbes, these pathogens handle copper in different but complementary ways to build larger and more active biofilms.
Could copper-based treatments replace antibiotics?
The findings suggest that copper-based approaches could help break these microbial communities down, as a potential way to think about targeting infections that are difficult to treat.
When reviewing clinical research on biofilms, look for studies that focus on interkingdom interactions.
Have you encountered or studied the challenges of treating mixed microbial infections? Share your thoughts or questions in the comments section below to join the conversation on the future of antimicrobial research.
